Ascentage Pharma Group International - American Depository Shares (AAPG)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- P/B of 208.83 — trading above book value
- Piotroski F-Score 6/9 — moderate financial health
- Loss-making — negative ROE of -148.0%
Ascentage Pharma Group International - American Depository Shares (AAPG) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $7.8 billion . Key value metrics: P/B ratio 208.83, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Ascentage Pharma Group International - American Depository Shares — Fundamental Analysis Summary
On financial health, AAPG shows a moderate Piotroski F-Score of 6/9, and negative return on equity of -148.0% (sector average: -20.6%), and high leverage with a debt-to-equity ratio of 6.09.
StockPik's composite Value Score for AAPG is 25/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.